Abstract
Purpose
A systematic review and meta-analysis were conducted to quantitatively synthesize the current evidence regarding the risk of developing metabolic syndrome (MetS) in women with a personal history of gestational diabetes mellitus (GDM), without pre-existing diabetes, compared with those without a history of GDM.
Methods
Four electronic databases [MEDLINE (via PubMed), Scopus, Cochrane Library, PROSPERO] were searched for relevant literature until July 29th 2020. Cochran’s Q test was applied for the assessment of heterogeneity. The random-effects model was applied by calculating the odds ratio (OR) and 95% confidence interval (CI) for each study. Publication bias was estimated with Egger’s linear regression test.
Results
The results from 23 studies (10,230 pregnant women; 5169 cases, 5061 controls), indicated that women with a history of GDM had a higher risk of developing MetS compared with those without such a history (OR 3.45; 95% CI 2.80–4.25, p < 0.0001). This risk remained higher, independently of maternal age and ethnicity (although the risk was not as high in Asians; OR 2.11; 95% CI 1.27–3.52). The risk of developing MetS was even higher in studies where women with GDM had increased body mass index (BMI) compared with the controls (OR 4.14; 95% CI 3.18–5.38).
Conclusions
The risk for developing MetS following delivery is higher in women with a history of GDM compared with women without such a history. Timely recognition and appropriate intervention are critical to halt progression to MetS and its associated morbidity.



Data availability
Not applicable.
Code availability
Not applicable.
Abbreviations
- ADA:
-
American Diabetes Association
- AHA/NHLBI:
-
American Heart Association/National Heart, Lung, and Blood Institute
- ALAD:
-
Latin American Diabetes Association
- apoB:
-
Apolipoprotein B
- BMI:
-
Body mass index
- BP:
-
Blood pressure
- CI:
-
Confidence interval
- CRP:
-
C-reactive protein
- CVD:
-
Cardiovascular disease
- Fig.:
-
Figure
- GDM:
-
Gestational diabetes mellitus
- HDL-c:
-
High-density lipoprotein cholesterol
- IADPSG:
-
International Association of Diabetes and Pregnancy Study Groups
- IDF:
-
International Diabetes Federation
- IFG:
-
Impaired fasting glucose
- MetS:
-
Metabolic syndrome
- NCEP-ATPIII:
-
National Cholesterol Education Program Adult Treatment Panel III criteria
- NDDG:
-
National Diabetes Data Group
- NICE:
-
National Institute for Health and Care Excellence
- NOS:
-
Newcastle–Ottawa scale
- OR:
-
Odds ratio
- PPAR:
-
Peroxisome proliferator-activated receptor
- T1DM:
-
Type 1 diabetes mellitus
- T2DM:
-
Type 2 diabetes mellitus
- TG:
-
Triglycerides
- WC:
-
Waist circumference
- WHO:
-
World Health Organization
- WHR:
-
Waist-to-hip ratio
References
American Diabetes Association (2015) 2. Classification and diagnosis of diabetes. Diabetes Care 38(Supplement 1):S8–S16
Behboudi-Gandevani S, Amiri M, Yarandi RB, Tehrani FR (2019) The impact of diagnostic criteria for gestational diabetes on its prevalence: a systematic review and meta-analysis. Diabetol Metab Syndr 11(1):11–11
ID Federation (2019) IDF diabetes atlas, 9th edn. ID Federation
Brody SC, Harris R, Lohr K (2003) Screening for gestational diabetes: a summary of the evidence for the US Preventive Services Task Force. Obstet Gynecol 101(2):380–392
Cypryk K, Pertyńska-Marczewska M, Szymczak W, Zawodniak-Szałapska M, Wilczyński J, Lewiński A (2005) Overweight and obesity as common risk factors for gestational diabetes mellitus (GDM), perinatal macrosomy in offspring and type-2 diabetes in mothers. Prz Lek 62(1):38–41
Schneider S, Bock C, Wetzel M, Maul H, Loerbroks A (2012) The prevalence of gestational diabetes in advanced economies. J Perinat Med 40:511–520. https://doi.org/10.1515/jpm-2012-0015
Guariguata L, Linnenkamp U, Beagley J, Whiting DR, Cho NH (2014) Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 103(2):176–185
Zhu Y, Zhang C (2016) Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective. Curr Diabetes Rep 16(1):7–7
Durnwald C (2015) Gestational diabetes: linking epidemiology, excessive gestational weight gain, adverse pregnancy outcomes, and future metabolic syndrome. Semin Perinatol 4:254–258
Wendland EM, Torloni MR, Falavigna M, Trujillo J, Dode MA, Campos MA, Duncan BB, Schmidt MI (2012) Gestational diabetes and pregnancy outcomes—a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth 12(1):23–23
Farrar D, Simmonds M, Bryant M, Sheldon TA, Tuffnell D, Golder S, Dunne F, Lawlor DA (2016) Hyperglycaemia and risk of adverse perinatal outcomes: systematic review and meta-analysis. BMJ 354:i4694–i4694
Wu P, Gulati M, Kwok CS, Wong CW, Narain A, O’Brien S, Chew-Graham CA, Verma G, Kadam UT, Mamas MA (2018) Preterm delivery and future risk of maternal cardiovascular disease: a systematic review and meta-analysis. J Am Heart Assoc 7(2):e007809
Lauenborg J, Crusell M, Mathiesen ER, Damm P (2020) Maternal long-term outcomes after a pregnancy complicated by gestational diabetes mellitus, vol 28. Karger Publishers, Basel, pp 223–233
Pathirana MM, Lassi ZS, Roberts CT, Andraweera PH (2020) Cardiovascular risk factors in offspring exposed to gestational diabetes mellitus in utero: systematic review and meta-analysis. J Dev Orig Health Dis. https://doi.org/10.1017/s2040174419000850
Nijs H, Benhalima K (2020) Gestational diabetes mellitus and the long-term risk for glucose intolerance and overweight in the offspring: a narrative review. J Clin Med 9(2):599–599
Smith GN, Louis JM, Saade GR (2019) Pregnancy and the postpartum period as an opportunity for cardiovascular risk identification and management. Obstet Gynecol 134(4):851–862
Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N (2014) Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract 105(2):141–150
Preis SR, Hwang S-J, Coady S, Pencina MJ, D’Agostino RB Sr, Savage PJ, Levy D, Fox CS (2009) Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes in the Framingham Heart Study, 1950–2005. Circulation 119(13):1728–1728
Andrei M, Alexandra M, Andra O, Constantin AR, Mihai R, Magdalena L-CM, Florin M (2018) Prevalence of metabolic syndrome and of cardiovascular risk factors. Intern Med 15(5):35–42
Kassi E, Pervanidou P, Kaltsas G, Chrousos G (2011) Metabolic syndrome: definitions and controversies. BMC Med 9(1):48–48
Povel CM, Boer JMA, Reiling E, Feskens EJM (2011) Genetic variants and the metabolic syndrome: a systematic review. Obes Rev 12(11):952–967
Mao H, Li Q, Gao S (2012) Meta-analysis of the relationship between common type 2 diabetes risk gene variants with gestational diabetes mellitus. PLoS ONE 7(9):e45882
Huopio H, Cederberg H, Vangipurapu J, Hakkarainen H, Pääkkönen M, Kuulasmaa T, Heinonen S, Laakso M (2013) Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes. Eur J Endocrinol 169(3):291–297
Berger JP, Akiyama TE, Meinke PT (2005) PPARs: therapeutic targets for metabolic disease. Trends Pharmacol Sci 26(5):244–251
Abranches MV, de Oliveira FE, Bressan J (2011) Peroxisome proliferator-activated receptor: effects on nutritional homeostasis, obesity and diabetes mellitus. Nutr hosp 26(2):271–279
Moher D, LIberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. BMJ (Open Access). https://doi.org/10.1136/bmj.b2535
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 283(15):2008–2012
Chackrewarthy S, Gunasekera D, Pathmeswaren A, Wijekoon CN, Ranawaka UK, Kato N, Takeuchi F, Wickremasinghe AR (2013) A comparison between revised NCEP ATP III and IDF definitions in diagnosing metabolic syndrome in an Urban Sri Lankan population: the Ragama Health Study. ISRN Endocrinol. https://doi.org/10.1155/2013/320176
Wells G, Shea B, O’Connell D, Peterson J (2000) The Newcastle–Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses
Kim HJ, Kim J-H, Chay DB, Park JH, Kim M-A (2017) Association of isolated single umbilical artery with perinatal outcomes: systemic review and meta-analysis. Obstet Gynecol Sci 60(3):266–273
Balduzzi S, Rücker G, Schwarzer G (2019) How to perform a meta-analysis with {R}: a practical tutorial. Evid Based Ment Health 22(4):153–160
Xu Y, Shen S, Sun L, Yang H, Jin B, Cao X (2014) Metabolic syndrome risk after gestational diabetes: a systematic review and meta-analysis. PLoS ONE 9(1):e87863
De Souza LR, Ray JG, Retnakaran R (2011) Gestational diabetes and the metabolic syndrome. In: Gestational diabetes. InTech Open, London
Clark CM, Qiu C, Amerman B, Porter B, Fineberg N, Aldasouqi S, Golichowski A (1997) Gestational diabetes: should it be added to the syndrome of insulin resistance? Diabetes Care 20(5):867–871
Anastasiou E, Lekakis JP, Alevizaki M, Papamichael CM, Megas J, Souvatzoglou A, Stamatelopoulos SF (1998) Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 21(12):2111–2115
Montelongo A, Lasunción MA, Pallardo LF, Herrera E (1992) Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes 41(12):1651–1659
Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444(7121):860–867
Haffner SM (2006) The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 97(2):3–11
Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R (2003) First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 26(3):819–824
Winzer C, Wagner O, Festa A, Schneider B, Roden M, Bancher-Todesca D, Pacini G, Funahashi T, Kautzky-Willer A (2004) Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitus. Diabetes Care 27(7):1721–1727
Stern M (1995) Diabetes and cardiovascular disease. The “common soil” hypothesis. Diabetes 44(4):369–374. https://doi.org/10.2337/diabetes.44.4.369
Budak MS, Kahramanoglu I, Vitale SG, Akgol S, Dilek ME, Kartal S, Caruso S, Kahveci B, Obut M, Bademkiran MH (2019) Maternal abdominal subcutaneous fat thickness as a simple predictor for gestational diabetes mellitus. J Perinat Med 47(6):605–610
Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B (2003) C-reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocrinol Metab 88(8):3507–3512
Retnakaran R, Qi Y, Connelly PW, Sermer M, Hanley AJ, Zinman B (2010) Risk of early progression to prediabetes or diabetes in women with recent gestational dysglycaemia but normal glucose tolerance at 3-month postpartum. Clin Endocrinol 73(4):476–483
Retnakaran R, Qi Y, Connelly PW, Sermer M, Zinman B, Hanley AJG (2010) Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab 95(2):670–677
Varner MW, Madeline Murguia R, Landon MB, Casey BM, Reddy UM, Wapner RJ, Rouse DJ, Tita ATN, Thorp JM, Chien EK et al (2017) Pregnancies after the diagnosis of mild gestational diabetes mellitus and risk of cardiometabolic disorders. Obstet Gynecol 129(2):273–273
Lauenborg J, Mathiesen E, Hansen T, Glumer C, Jørgensen T, Borch-Johnsen K, Hornnes P, Pedersen O, Damm P (2005) The prevalence of the metabolic syndrome in a Danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab 90(7):4004–4010
Bo S, Menato G, Botto C, Cotrino I, Bardelli C, Gambino R, Cassader M, Durazzo M, Signorile A, Massobrio M et al (2006) Mild gestational hyperglycemia and the metabolic syndrome in later life. Metab Syndr Relat Disord 4(2):113–121
Bo S, Monge L, Macchetta C, Menato G, Pinach S, Uberti B, Pagano G (2004) Prior gestational hyperglycemia: a long-term predictor of the metabolic syndrome. J Endocrinol Investig 27(7):629–635
Bo S, Menato G, Gallo ML, Bardelli C, Lezo A, Signorile A, Gambino R, Cassader M, Massobrio M, Pagano G (2004) Mild gestational hyperglycemia, the metabolic syndrome and adverse neonatal outcomes. Acta Obstet Gynecol Scand 83(4):335–340
Akinci B, Celtik A, Yuksel F, Genc S, Yener S, Secil M, Ozcan MA, Yesil S (2011) Increased osteoprotegerin levels in women with previous gestational diabetes developing metabolic syndrome. Diabetes Res Clin Pract 91(1):26–31
Lorenzo-Almoros A, Hang T, Peiro C, Soriano-Guillén L, Egido J, Tuñón J, Lorenzo O (2019) Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases. Cardiovasc Diabetol 18(1):140
Hakkarainen H, Huopio H, Cederberg H, Voutilainen R, Heinonen S (2018) Future risk of metabolic syndrome in women with a previous LGA delivery stratified by gestational glucose tolerance: a prospective cohort study. BMC Pregnancy Childbirth 18(1):326–326
Powe CE, Allard C, Battista M-C, Doyon M, Bouchard L, Ecker JL, Perron P, Florez JC, Thadhani R, Hivert M-F (2016) Heterogeneous contribution of insulin sensitivity and secretion defects to gestational diabetes mellitus. Diabetes Care 39(6):1052–1055
Wani K, Sabico S, Alnaami AM, Al-Musharaf S, Fouda MA, Turkestani IZ, Al-Ajlan A, Alshingetti NM, Alokail MS, Al-Daghri NM (2020) Early-pregnancy metabolic syndrome and subsequent incidence in gestational diabetes mellitus in Arab women. Front Endocrinol 11:98
Verma A, Boney CM, Tucker R, Vohr BR (2002) Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J Clin Endocrinol Metab 87(7):3227–3235
Albareda M, Caballero A, Badell G, Rodríguez-Espinosa J, Ordóñez-Llanos J, de Leiva A, Corcoy R (2005) Metabolic syndrome at follow-up in women with and without gestational diabetes mellitus in index pregnancy. Metabolism 54(8):1115–1121
Wijeyaratne CN, Waduge R, Arandara D, Arasalingam A, Sivasuriam A, Dodampahala SH, Balen AH (2006) Metabolic and polycystic ovary syndromes in indigenous South Asian women with previous gestational diabetes mellitus. BJOG Int J Obstet Gynaecol 113(10):1182–1187
Kousta E, Efstathiadou Z, Lawrence NJ, Jeffs JAR, Godsland IF, Barrett SC, Dore CJ, Penny A, Anyaoku V, Millauer BA et al (2006) The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes. Diabetologia 49(1):36–40
Tam WH, Yang XL, Chan JCN, Ko GTC, Tong PCY, Ma RCW, Cockram CS, Sahota D, Rogers MS (2007) Progression to impaired glucose regulation, diabetes and metabolic syndrome in Chinese women with a past history of gestational diabetes. Diabetes/Metab Res Rev 23(6):485–489
Di Cianni G, Lencioni C, Volpe L, Ghio A, Cuccuru I, Pellegrini G, Benzi L, Miccoli R, Del Prato S (2007) C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes/Metab Res Rev 23(2):135–140
Wender-Ozegowska E, Sporna M, Zawiejska A, Sporna A, Brazert J (2007) Components of metabolic syndrome in women after gestational diabetes. Pol Arch Med Wewn 117(10):457–457
Krishnaveni GV, Hill JC, Veena SR, Geetha S, Jayakumar MN, Karat CLS, Fall CHD (2007) Gestational diabetes and the incidence of diabetes in the 5 years following the index pregnancy in South Indian women. Diabetes Res Clin Pract 78(3):398–404
Costacou T, Bosnyak Z, Harger GF, Markovic N, Silvers N, Orchard TJ (2008) Postpartum adiponectin concentration, insulin resistance and metabolic abnormalities among women with pregnancy-induced disturbances. Prev Cardiol 11(2):106–115
Madarász E, Tamás G, Tabák ÁG, Kerényi Z (2009) Carbohydrate metabolism and cardiovascular risk factors 4 years after a pregnancy complicated by gestational diabetes. Diabetes Res Clin Pract 85(2):197–202
Akinci B, Celtik A, Yener S, Yesil S (2010) Prediction of developing metabolic syndrome after gestational diabetes mellitus. Fertil Steril 93(4):1248–1254
Tam W-H, Ma RC-W, Yang X, Ko GT-C, Lao TT-H, Chan MH-M, Lam CW-K, Cockram CS, Chan JC-N (2012) Cardiometabolic risk in Chinese women with prior gestational diabetes: a 15-year follow-up study. Gynecol Obstet Investig 73(2):168–176
Edalat B, Sharifi F, Badamchizadeh Z, Hossein-Nezhad A, Larijani B, Mirarefin M, Fakhrzadeh H (2013) Association of metabolic syndrome with inflammatory mediators in women with previous gestational diabetes mellitus. J Diabetes Metab Disord 12(1):8
Vilmi-Kerälä T, Palomäki O, Vainio M, Uotila J, Palomäki A (2015) The risk of metabolic syndrome after gestational diabetes mellitus—a hospital-based cohort study. Diabetol Metab Syndr 7(1):43–43
Hakkarainen H, Huopio H, Cederberg H, Pääkkönen M, Voutilainen R, Heinonen S (2016) The risk of metabolic syndrome in women with previous GDM in a long-term follow-up. Gynecol Endocrinol 32(11):920–925
Nouhjah S, Shahbazian H, Shahbazian N, Jahanfar S, Jahanshahi A, Cheraghian B, Mohammadi ZD, Ghodrati N, Houshmandi S (2018) Early postpartum metabolic syndrome in women with or without gestational diabetes: results from Life after Gestational Diabetes Ahvaz cohort study. Diabetes Metab Syndr Clin Res Rev 12(3):317–323
Li L-J, Aris IM, Su LL, Chong YS, Wong TY, Tan KH, Wang JJ (2018) Effect of gestational diabetes and hypertensive disorders of pregnancy on postpartum cardiometabolic risk. Endocr Connect 7(3):433–442
Shen Y, Li W, Leng J, Zhang S, Liu H, Li W, Wang L, Tian H, Chen J, Qi L et al (2019) High risk of metabolic syndrome after delivery in pregnancies complicated by gestational diabetes. Diabetes Res Clin Pract 150:219–226
Funding
No funding was received.
Author information
Authors and Affiliations
Contributions
AT, TD and MC conceived the study. AT and AS performed data extraction and quality assessment of the included studies. AT carried out the statistical analysis of the data. AA and IT resolved any disagreements between AT and AS. TD, MC, IT, AM and DG assessed the quality of the manuscript. AT drafted the manuscript. MC, TD and DG critically revised the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
Not applicable.
Informed consent
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tranidou, A., Dagklis, T., Tsakiridis, I. et al. Risk of developing metabolic syndrome after gestational diabetes mellitus - a systematic review and meta-analysis. J Endocrinol Invest 44, 1139–1149 (2021). https://doi.org/10.1007/s40618-020-01464-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-020-01464-6